The TrumpRx platform currently focuses on a limited group of high-cost brand-name medications, particularly those that have generated significant attention due to rising demand and pricing concerns
SODIUM-GLUCOSE COTRANSPORTER TYPE 2 (SGLT2) INHIBITORS They are antihyperglycemic agents that act on SGLT-2 proteins, expressed in the proximal convoluted tubules
Federal Register 89 Formichi C, et al (2024) Real-world use of oral versus subcutaneous semaglutide in a cohort of type 2 diabetic patients: which option to which patient
Navarro-Gonzalez JF, Sanchez-Nino MD, Donate-Correa J, et al
These discussions are limited to in vitro and in vivo research models and do not imply approved applications, outcomes, or therapeutic use
Several people also report improved metabolism, better energy, and a general sense of well-being